Next, we analyzed patients' survival and found that low expression of ABCC4 indicated better overall survial for prostate cancer patients both in TCGA database and in our own Tongji Cohort (Figure 1D and 1E). The gene discussed is ABCC4; the disease is Familial prostate cancer.